These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 11707164)

  • 21. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
    Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
    Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comorbid attention deficit/hyperactivity disorder and substance use disorder: treatment considerations.
    Klassen LJ; Bilkey TS; Katzman MA; Chokka P
    Curr Drug Abuse Rev; 2012 Sep; 5(3):190-8. PubMed ID: 22571450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Attention deficit hyperactivity disorder and substance use in adulthood-Guideline-conform diagnostics and treatment].
    Kölle M; Philipsen A; Mackert S
    Nervenarzt; 2023 Jan; 94(1):47-57. PubMed ID: 36633607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attention-deficit/hyperactivity disorder and associated childhood disorders.
    Dunne JE
    Prim Care; 1999 Jun; 26(2):349-72. PubMed ID: 10318752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult Attention-Deficit Hyperactivity Disorder/Substance Use Disorder Dual Disorder Patients: A Dual Disorder Unit Point of View.
    Maremmani I; Spera V; Maiello M; Maremmani AGI; Perugi G
    Curr Top Behav Neurosci; 2022; 57():179-198. PubMed ID: 35507285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV; Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.
    Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA;
    Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent Deficits in Self-Regulation as a Mediator between Childhood Attention-Deficit/Hyperactivity Disorder Symptoms and Substance Use Disorders.
    Cavicchioli M; Ogliari A; Movalli M; Maffei C
    Subst Use Misuse; 2022; 57(12):1837-1853. PubMed ID: 36096483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attention deficit/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations.
    Sullivan MA; Rudnik-Levin F
    Ann N Y Acad Sci; 2001 Jun; 931():251-70. PubMed ID: 11462745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinical perspective of attention-deficit/hyperactivity disorder into adulthood.
    Wilens TE; Dodson W
    J Clin Psychiatry; 2004 Oct; 65(10):1301-13. PubMed ID: 15491232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapy for adult ADHD.
    Adler LA
    J Clin Psychiatry; 2009 May; 70(5):e12. PubMed ID: 19552859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homovanillic acid (HVA) plasma levels inversely correlate with attention deficit-hyperactivity and childhood neglect measures in addicted patients.
    Gerra G; Leonardi C; Cortese E; Zaimovic A; Dell'agnello G; Manfredini M; Somaini L; Petracca F; Caretti V; Saracino MA; Raggi MA; Donnini C
    J Neural Transm (Vienna); 2007; 114(12):1637-47. PubMed ID: 17690947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A DSM-IV Axis I comorbidity study of males (n = 120) with paraphilias and paraphilia-related disorders.
    Kafka MP; Hennen J
    Sex Abuse; 2002 Oct; 14(4):349-66. PubMed ID: 12375492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attention deficit hyperactivity disorder and substance use disorders.
    Szobot CM; Bukstein O
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oppositional defiant disorder in adults with ADHD.
    Reimherr FW; Marchant BK; Olsen JL; Wender PH; Robison RJ
    J Atten Disord; 2013 Feb; 17(2):102-13. PubMed ID: 22100691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attention deficit hyperactivity disorder and dual disorders. Educational needs for an underdiagnosed condition.
    Martinez-Raga J; Szerman N; Knecht C; de Alvaro R
    Int J Adolesc Med Health; 2013; 25(3):231-43. PubMed ID: 23846135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.
    Schubiner H
    CNS Drugs; 2005; 19(8):643-55. PubMed ID: 16097847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.
    Wigal SB
    CNS Drugs; 2009; 23 Suppl 1():21-31. PubMed ID: 19621975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse.
    Elkins IJ; McGue M; Iacono WG
    Arch Gen Psychiatry; 2007 Oct; 64(10):1145-52. PubMed ID: 17909126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.